NR4A1 and hepatocellular carcinoma: The glycolytic regulation was required for Nur77 to suppress HCC cell proliferation, as treatment of 2-DG, an inhibitor for glycolysis, almost abolished Nur77 effect on cell proliferation (Supplementary Fig. 7a, b).